Sulbactam combined with tigecycline improves outcomes in patients with severe multidrug-resistant Acinetobacter baumannii pneumonia - Deng, Yanling; Chen, Lin; Yue, Mingrui; Huang, Xiaobo; Yang, Yang; Yu, Hua (BMC infectious diseases, 2022)
Keywords: Acinetobacter baumannii; Acinetobacter Infections - drug therapy; Anti-Bacterial Agents - pharmacology; Anti-Infective Agents - therapeutic use; Antibiotics; Antiinfectives and antibacterials; Bacterial pneumonia; Carbapenem-resistant Acinetobacter baumannii(CRAB); Carbapenems - therapeutic use; Catheters; Causes of; Dosage and administration; Drug dosages; Drug resistance; Drug Resistance, Multiple, Bacterial; Drug therapy; Humans; Infectious Diseases; Intensive care unit; Internal Medicine; Intubation; Laboratories; Mechanical ventilation; Medical instruments; Medical Microbiology; Medical prognosis; Medicine; Medicine & Public Health; Microbial Sensitivity Tests; Mortality; Multi-drug resistant Acinetobacter baumannii (MDR-AB); Multidrug resistance; Multidrug resistant organisms; Normal distribution; Nosocomial infections; Parasitology; Patient outcomes; Patients; Placement; Pneumonia; Pneumonia - drug therapy; Retrospective Studies; Severe pneumonia; Sulbactam; Sulbactam - therapeutic use; Tigecycline; Tigecycline - pharmacology; Tropical Medicine; Ventilation; Ventilators; China; Multi-drug resistant; Carbapenem-resistant; MDR-AB; Severe pneumonia; Intensive care unit; CRAB; Carbapenem-resistant Acinetobacter baumannii(CRAB); Multi-drug resistant Acinetobacter baumannii (MDR-AB)